Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic
02 févr. 2021 04h43 HE
|
Research and Markets
Dublin, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized...
Global Companion Diagnostics Market Growth, Trends, and Forecasts Report 2020-2025: Companies Promoting Personalized Medicine and Targeted Therapy as a New Treatment Option
30 déc. 2020 08h43 HE
|
Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Companion Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The growth of...
Global Next-Generation Breast Cancer Diagnostic and Screening Market 2020-2030: Focus on Products, Technologies, Cancer Sub-Type, End Users,, and Competitive Landscape
17 sept. 2020 04h08 HE
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Next-Generation Breast Cancer Diagnostic and Screening Market: Focus on Products, Technologies, Cancer Sub-Type, End Users, Country Data (14...
Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in China
28 juin 2020 21h00 HE
|
Burning Rock Biotech Limited
SHANGHAI, China, June 28, 2020 (GLOBE NEWSWIRE) -- On June 29, 2020, Burning Rock Biotech Limited (NASDAQ: BNR) announced a strategic partnership with CStone Pharmaceuticals (HKEX: 2616) to...
Exosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) Inhibitor
14 mars 2018 07h30 HE
|
Exosome Diagnostics
Boston, MA, March 14, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a market leader in liquid biopsy and the world’s first exosome-based diagnostics company announces a collaboration...
Exosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems Biology
09 janv. 2018 07h46 HE
|
Exosome Diagnostics
Waltham, MA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has placed an Early Access version of its commercial Shahky system, which quantitively measures exosomal proteins, at...
CDx CEO Daniel Yazbeck Featured Panelist at Marijuana Investor, Technology and Healthcare Events
16 avr. 2015 11h49 HE
|
CDx Inc.
LA JOLLA, Calif., April 16, 2015 (GLOBE NEWSWIRE) -- CDx, Inc., developers of MyDx (My Diagnostic), the first handheld analyzer technology for the cannabis industry, is on a mission to help consumers...